CIK 0001818794 · Large accelerated filer
Dyne Therapeutics, Inc.
Sign in to watch- Ticker
- DYN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364883909
- Phone
- (781) 786-8230
- Business address
- 1560 TRAPELO ROAD, WALTHAM, MA, 02451
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 2,000 shares at $16.94 ($33,880)
- 8-K Event Shareholder vote results
- 4 Open-market buy Director bought 2,500 shares at $17.48 ($43,700)
- 8-K Event Regulation FD disclosure · Other events
- 4 Open-market buy Director bought 2,000 shares at $18.21 ($36,420)
- 4 Open-market buy Director bought 2,500 shares at $17.12 ($42,800)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale Chief Commercial Officer sold 228 shares at $18.36 ($4,186)
- 4 Planned sale Chief Medical Officer sold 1,564 shares at $18.36 ($28,715)
- 4 Planned sale Chief Financial Officer sold 1,448 shares at $18.36 ($26,585)
- 4 Planned sale CEO & President sold 3,311 shares at $18.36 ($60,790)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Planned sale Director sold 106,723 shares at an average $18.14 ($1,936,341)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 5 of 40 · 796 filings